Chris Welsh

Chris Welsh is currently serving as the Vice President of Medical Affairs at TGaS Advisors since February 2019. Prior to that, Chris held the position of Executive Director and Head of Medical Affairs at Lipocine Inc. from September 2016 to October 2018. With a background in pharmaceuticals, Chris has also worked at various other companies in roles such as Director of Medical Affairs at Orexo US, Inc. and in various positions at Shire Pharmaceuticals. Chris holds an MBA from Villanova University and a PharmD from the University of the Sciences in Philadelphia.